SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-23-006836
Filing Date
2023-09-13
Accepted
2023-09-13 16:00:42
Documents
2
Period of Report
2023-09-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1745
2 CARDAMA POA cardamaex24.txt EX-24 3560
  Complete submission text file 0001562180-23-006836.txt   6717
Mailing Address C/O TCR2 THERAPEUTICS INC. 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address
Cardama Alfonso Quintas (Reporting) CIK: 0001760104 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39634 | Film No.: 231252618

Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Issuer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences